Head-to-head · Value Score
CoreAge Rx vs Levers Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Levers Health a 64. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLevers Health
#330 · Grade C · Watch List
Est. first month
From $247/mo (1.25 mg dose, compounded)
Save ~82% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 64 — an est. $99/mo first month, with no teaser step-up baked in. Levers Health isn't out of it: Someone staying on a low dose, or specifically looking for a microdose protocol.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Levers Health |
|---|---|---|
| Value Score | 93 (A+) | 64 (C) |
| Est. first month | $99/mo | From $247/mo (1.25 mg dose, compounded) |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $99/mo | From $247/mo (1.25 mg dose, compounded) |
| Tirzepatide | $149/mo | From $296/mo (5 mg dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Levers Health
Levers Health sells compounded semaglutide from $247 and tirzepatide from $296 on dose-capped plans, plus a separate low-dose and microdose GLP-1 line aimed at longevity rather than weight loss.
Why it's a deal
- Runs a distinct low-dose and microdose GLP-1 line for metabolic optimization, which most weight-loss sellers do not offer separately
- Prices for each plan are published on the storefront rather than quoted after an intake
- Both molecules are available alongside sermorelin on the same account
The fine print
- The advertised $296 tirzepatide plan caps at 5 mg — the any-dose plan is $396, so the headline does not survive titration
- $247 semaglutide is above the roughly $179 median tracked here before any dose step-up
- No LegitScript or PCAB accreditation is displayed, and no physical address is published
- Neither the FAQ nor the terms page loads, so the cancellation and refund terms cannot be read before signing up
- The states it serves are not disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Levers Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.